Cytokinetics (NASDAQ: CYTK) is up 36% since FBR Capital analyst, Vernon Bernadino, chose the stock as an FBR Alpha Generator ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE